Clinical Trials Directory

Trials / Completed

CompletedNCT01033903

Optimal Treatment of Miscarriage

Which is the Optimal Treatment for Miscarriage With a Gestational ac in the Uterus and Which Factors Can Predict if the Treatment Will be Successful?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
190 (actual)
Sponsor
Region Skane · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.

Conditions

Interventions

TypeNameDescription
DRUGmisoprostol800 micrograms intravaginally ONCE

Timeline

Start date
2008-10-01
Primary completion
2015-12-01
Completion
2018-03-01
First posted
2009-12-17
Last updated
2018-10-22

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01033903. Inclusion in this directory is not an endorsement.

Optimal Treatment of Miscarriage (NCT01033903) · Clinical Trials Directory